New Hope for Alzheimers Treatment

There is now widespread agreement among research scientists and medical professionals that Alzheimer's Disease (AD) is a problem quickly growing to vast proportions. As the life expectancy of Americans continues to rise, increasing the percentage of the population over 65 years of age, so does the number of Alzheimer's cases.

It is currently estimated that people over 65 years of age have a 10% chance of developing Alzheimer's, while those over 85 have a 50% likelihood of developing AD, making it the leading cause of dementia among older people. Though the disease is associated primarily with memory loss, its effects also comprise a number of other severe disabilities, including changes in personality, disorientation, difficulty with speech and comprehension, and a lack of ability to move normally.

Consequently, most Alzheimer's patients require a great deal of care, costing society close to $100 billion annually. According to Christian Fritze, Ph.D., Director of the Antibody Products Division at Covance Research Products, "The impact of Alzheimer's Disease on our society will only increase as our population ages. The prevalence of the disease and disabling effects on the patient are significant by themselves. In addition we are becoming increasingly aware of the far-reaching effects on families, care-giver networks and the economics of our health care system. The drive for progress towards effective treatments by the research and drug development community is growing stronger every day."

A New Consensus

But recent developments in the medical research community do provide some hope. During the last two years, there has been a growing consensus among Alzheimer researchers about the cause of Alzheimer's disease, providing focus for scientists exploring the new treatment options.

The focus is on amyloid beta oligomers, a new wrinkle on an older hypothesis called the "amyloid cascade hypothesis". Widespread acceptance of this new conclusion is something of a milestone in the history of Alzheimer's research. As Dr. Fritze says, "The decades old quest for the causative agent in Alzheimer's Disease has recently focused on the precursors of amyloid plaques. These precursors are part of a bewildering array of processed (APP) Amyloid Precursor Protein) variants, Tau isoforms and secretase components that play a role in neuronal cytotoxicity and subsequent brain dysfunction."

Amyloid plaques are sticky protein deposits in the brain containing amyloid beta peptide. Researchers have associated the buildup of this plaque with Alzheimer's disease since its discovery in 1907. But despite the clear correlation, scientists were not sure what, exactly, spurred the onset of Alzheimer's Disease.

The hypothesis that amyloid beta accumulation in the brain is the major cause of Alzheimer's Disease1 has been the focus of much attention over the past decade. Although this hypothesis was the leading explanation for the cause of AD, it had several weaknesses. The most obvious problem with the theory was the fact that the buildup of amyloid beta peptides did not necessarily correspond with the severity of Alzheimer's symptoms.

However, in 19982 and in 20023, researchers proposed that it was not the amyloid beta plaques themselves that were neurotoxic ? and therefore the cause of Alzheimer's ? but rather precursors to amyloid beta plaques formed by smaller aggregates of amyloid beta. These new ideas are gaining widespread acceptance among the Alzheimer's research community, creating a consensus that had not existed before.

This new focus provides one more spur to action for Alzheimer's researchers, and underscores the need for further advancement. "The AD field demands sophisticated, highly-sensitive research tools to track these components and quantitate the existence of monomeric, oligomeric and fibrillar amyloid forms present in the progression of Alzheimer's disease," says Dr. Fritze.

Antibody Treatment

Two new studies, both released in October 20044, suggest that new treatment options may be on the horizon. The studies are the modification of one of two previous attempts using amyloid beta (Aβ) antibodies in the treatment of Alzheimer's Disease. The previous attempts, though not successful, did at least suggest new courses of action in Alzheimer's research and provided invaluable information for researchers.

In the first of the two previous attempts, researchers injected the antigen itself ? pieces of the beta amyloid protein that makes up amyloid plaque ? into mice, in the hopes that the injections would generate an immune (antibody) response against amyloid. Results were initially positive. The injected antigen produced Aβ antibodies and slowed the onset of the disease by decreasing Aβ levels. However, when tried on humans, the procedure led to meningoencephalitis (an inflammation of tissue around the brain) in some patients, and was therefore halted.

In the second attempt, a passive immunity therapy was tried in which antibodies to amyloid beta (not amyloid protein) were injected into mice, but hemorrhaging and inflammation ensued due to the high antibody doses required to be effective.

New Hope

But now there appears to be new hope for the use of antibodies as therapeutic agents for the treatment of Alzheimer's patients. In the first of the two new studies that appeared in October conducted by the National Institute for Longevity Sciences, NCGG, and the Center for Neurological Diseases, Brigham & Women's College, Harvard Institute of Medicine, researchers modified the first procedure. Concluding that the meningoenchaphalitis which occurred in some patients was caused by autoimmune T-cell activation, the researchers hoped to develop a vaccine that could minimize this T-cell activation while retaining the production of Aß antibodies.

To accomplish this they created an oral vaccine that attached Aß DNA to an adeno-associated virus vector, which served to mitigate T-cell activation. Thus they were able to decrease Aß levels in the brains of the mice and yet not activate T-cells to the degree they had before, greatly reducing the risk of meningoencephalitis.

In the other new study, conducted at the University of Illinois at Chicago, researchers succeeded in making the passive immunity protocol much safer. This they accomplished by changing the point of entry for the Aß antibodies. Rather than injecting the antibodies into the body of the mice, as was done previously, antibody was injected directly into the brain of the mice. Because the antibodies were injected directly into the brain, smaller doses were needed, and side effects were minimized.

The results of the above studies, and the potential for further optimized immunization strategies may prove to be watershed events in the history of Alzheimer's treatment.

Covance is a leading provider of innovative antibody products and custom antibody development services to the research community for Alzheimer's disease. Visit www.Covance.com for more in-depth information and to view the suite of products for Alzheimer's disease. Boris Predovich is Vice President of Immunology and Surgical Services at Covance Research Products.

Notes

1. J.A. Hardy, G.A. Higgins (1992), Science, 256:184-5.
2. M.P. Lambert et al (1998), Proc Natl Acad Sci, 95:6448-53.
3. D.M. Walsh et al (2002), Nature, 416:535-9.
4. Neelima B. Chauhan et al (2004), Journal of Neuroscience Research, 78, 5:732-741.
Hideo Hara et al (2004), Journal of Alzheimer's Disease, 6, 5:483-488.

R. L. Fielding writes on many health-related topics.

---

Google News Updated : Fri, 22 Aug 2008 00:13:38 GMT Marlins let one slip away in San Francisco - Sports Network The Associated Press Marlins let one slip away in San Francisco Sports Network - 39 minutes ago San Francisco, CA (Sports Network) - Marlins reliever Kevin Gregg's wild pitch in bottom of the ninth inning scored Emmanuel Burriss to send San Francisco past Florida, 4-3, in the finale of a three-game series. Giants walk off on Gregg's wild pitch MLB.com Giants beat Marlins on wild pitch in 9th inning The Associated Press San Jose Mercury News - Rotoworld.com - Akron Farm Report - Flamarlins.com all 81 news articles Publ.Date : Thu, 21 Aug 2008 23:33:45 GMT Microsoft's Photosynth wilts under pressure - Computerworld Washington Post Microsoft's Photosynth wilts under pressure Computerworld - 44 minutes ago By Gregg Keizer August 21, 2008 (Computerworld) Within hours of its launch, Microsoft Corp.'s new photo-stitching service went dark, overwhelmed by demand, the company said Thursday afternoon. New Microsoft photo site spends first day offline The Associated Press New Microsoft Tech Converts Photo Soup Into 3-D Image TechNewsWorld InformationWeek - PC Magazine - TG Daily - Christian Science Monitor all 323 news articles Publ.Date : Thu, 21 Aug 2008 23:28:59 GMT My Super Sweet 16: The Miley Cyrus Edition - E! Online E! Online My Super Sweet 16: The Miley Cyrus Edition E! Online - 3 hours ago Miley Cyrus is about to show up all those spoiled brats on My Super Sweet 16 who think they're cool being flown to their party by helicopter or when they're carried in like a princess by a group of hot dudes. Miley Cyrus to Celebrate Turning 16 at Disneyland People Magazine Miley Cyrus Sweet 16 KFSN Press-Enterprise - The Gossip Girls - United Press International - Best Syndication all 87 news articles Publ.Date : Thu, 21 Aug 2008 20:21:48 GMT GM to Invest $500 Million To Build Chevy Cruze - Wall Street Journal Turkish Press GM to Invest $500 Million To Build Chevy Cruze Wall Street Journal - 3 hours ago By KATHY SHWIFF General Motors Corp. will spend more than $500 million in the US to build the Chevrolet Cruze, a next-generation compact car. GM announces $500M investment for small car The Associated Press GM to invest $500 million in small car plant MarketWatch Reuters - CNNMoney.com - CNET News - BloggingStocks all 266 news articles Publ.Date : Thu, 21 Aug 2008 21:10:12 GMT UPDATE 1-Microsoft enlists Seinfeld for ad campaign--source - Reuters UPDATE 1-Microsoft enlists Seinfeld for ad campaign--source Reuters - 2 hours ago By Steve Gorman LOS ANGELES, Aug 21 (Reuters) - Comedian Jerry Seinfeld will star in a $300 million marketing campaign for Microsoft Corp aimed at burnishing the image of its computer operating system, a person familiar with the effort said on Thursday ... Jerry Seinfeld and Bill Gates to star in anti-Apple ads TG Daily Seinfeld to be pitchman for Microsoft The Associated Press Slashdot - Bizjournals.com - GameSHOUT - Ars Technica all 474 news articles Publ.Date : Thu, 21 Aug 2008 21:27:28 GMT IAC Officially Breaks Up - Wall Street Journal Los Angeles Times IAC Officially Breaks Up Wall Street Journal - 55 minutes ago By DAVID BENOIT and KATHY SHWIFF IAC is left as a collection of more than 35 Internet companies -- including search engine Ask.com, dating site Match. IAC: And Then There Were Five Forbes Diller's IAC Split May Fail to Boost Investor Returns (Update2) Bloomberg The Associated Press - MarketWatch - FOXBusiness - CNNMoney.com all 280 news articles Publ.Date : Thu, 21 Aug 2008 23:17:40 GMT Hillary Clinton's Staff Looking to Avoid Embarrassing Anti-Obama ... - FOXNews Times Online Hillary Clinton's Staff Looking to Avoid Embarrassing Anti-Obama ... FOXNews - 58 minutes ago Hillary Clinton's staff is trying to avoid an embarrassing anti-Obama demonstration by her supporters during the floor vote at next week's Democratic convention in Denver. Clinton Will Attend Fund-Raiser for Towns New York Times Clinton for VP? She Says Ask the Obama Campaign ABC News CNN Political Ticker - New York Times Blogs - Newsweek - U.S. News & World Report all 546 news articles Publ.Date : Thu, 21 Aug 2008 23:15:16 GMT Add RSS Feeds To My Web Pages More Web Site Traffic

PARLOT::Ebooks, Scripts, Websites, and more...

Adsense websites

Paying For Elder Care Just Got Easier

It's not a surprise that thousands of families across the... Read More

Solitary Confinement -- for Life

Sixty-five year old Arthur Jones served a self-imposed life sentence... Read More

If Using The Stairs Has Become A Daily Struggle, A Stair lift Could Change Your Life

Using stairs is an everyday nightmare for many people. As... Read More

Marketing, Selling, and Serving the Older Adult, Senior Citizens, Family Caregivers

Are your clients pleased by the fine quality service that... Read More

Exercise Walking For Seniors: Preventing Foot Problems

Exercise has a very important role in the general health... Read More

5 Myths You Should Know Before Choosing Elder Care

Myths associated with selecting quality nursing home care suggest quick... Read More

Scaling Down (Almost) Painlessly

Moving to a smaller house or apartment in a retirement... Read More

Arizona Senior Housing: Care Options for Seniors Who Can No Longer Live Alone

The following are a few of the care options available... Read More

Advocate For Senior Citizens ? Protecting Against Abuse and Fraud

Ruth is 87 years old this year and has been... Read More

Long Term In-home Care Options

Are you worried that you may lose all your life's... Read More

Just Give Them a Lot of Love and You?ll be Fine

It was right about this time, 19 years ago. My... Read More

Respiratory Help Is Available For Seniors With COPD

As HMOs Continue to Drop Coverage for Seniors - Now... Read More

Mom Wont Participate!

Q: Six months ago we placed my mother in an... Read More

Why Everyone Over 50 Should be Training for the Senior Games

by Phil Campbell, M.S., M.A., FACHE Senior Games participant and... Read More

Honey, Where Are The Car Keys?

Q: My mother is always losing, hiding and hoarding things,... Read More

Stair Lift Buying Guide

There is no doubt that having a stair lift in... Read More

Whos Gonna Take Care of You When Youre Old?

I finally went to the doctor this morning for my... Read More

Strategies on Paying for Nursing Home Care and Medicaid

The decision to place your loved one into a nursing... Read More

What Colour was Your Great-grandmothers Hair?

I've just made another Photoshop video. This one is about... Read More

Senior Living: 5 Ways to Help Reduce the Risk of Falling

Every year we hear stories of seniors falling, ending up... Read More

The Golden Years

1) What does Adrian Mitchell say we do to people... Read More

Helping Caregivers Get Comfortable Asking For Help

Becoming a care giver might not have been a conscious... Read More

Long Term-Care; 70 Million Americans Will Be Over 65 by 2003

We will all grow old; this is a given. We... Read More

Second Hand Stair Lifts

Buying second hand stair lifts is a viable and cost... Read More

Short Trips Can Stimulate Alzheimers Patients

Severe degradation of short-term memory means that my father, an... Read More